Alliancebernstein L.P. Sells 23,761 Shares of Teleflex Incorporated (NYSE:TFX)

Alliancebernstein L.P. lowered its stake in Teleflex Incorporated (NYSE:TFX - Free Report) by 4.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 511,007 shares of the medical technology company's stock after selling 23,761 shares during the quarter. Alliancebernstein L.P. owned approximately 1.10% of Teleflex worth $90,949,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of the stock. Avior Wealth Management LLC increased its stake in shares of Teleflex by 81.2% during the 4th quarter. Avior Wealth Management LLC now owns 279 shares of the medical technology company's stock worth $50,000 after purchasing an additional 125 shares during the last quarter. IFP Advisors Inc increased its position in Teleflex by 238.5% during the fourth quarter. IFP Advisors Inc now owns 308 shares of the medical technology company's stock worth $55,000 after buying an additional 217 shares during the last quarter. Exchange Traded Concepts LLC raised its stake in Teleflex by 38.2% in the fourth quarter. Exchange Traded Concepts LLC now owns 340 shares of the medical technology company's stock valued at $61,000 after buying an additional 94 shares during the period. R Squared Ltd bought a new stake in Teleflex in the fourth quarter valued at approximately $64,000. Finally, Kohmann Bosshard Financial Services LLC acquired a new stake in shares of Teleflex in the fourth quarter valued at approximately $73,000. Institutional investors own 95.62% of the company's stock.

Teleflex Price Performance

Shares of NYSE TFX traded down $0.69 during midday trading on Tuesday, reaching $130.00. The company's stock had a trading volume of 114,089 shares, compared to its average volume of 1,062,066. The company has a market cap of $6.03 billion, a P/E ratio of 25.83, a P/E/G ratio of 1.73 and a beta of 1.19. Teleflex Incorporated has a fifty-two week low of $127.18 and a fifty-two week high of $249.90. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. The business's 50 day moving average price is $153.81 and its two-hundred day moving average price is $185.45.

Teleflex (NYSE:TFX - Get Free Report) last released its earnings results on Thursday, February 27th. The medical technology company reported $3.89 earnings per share for the quarter, beating analysts' consensus estimates of $3.86 by $0.03. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The firm had revenue of $795.40 million during the quarter, compared to the consensus estimate of $813.24 million. On average, analysts forecast that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, March 17th. Shareholders of record on Friday, March 7th were issued a $0.34 dividend. This represents a $1.36 annualized dividend and a yield of 1.05%. The ex-dividend date was Friday, March 7th. Teleflex's dividend payout ratio is currently 95.77%.

Wall Street Analyst Weigh In

TFX has been the topic of a number of research analyst reports. Citizens Jmp cut Teleflex from an "outperform" rating to a "market perform" rating in a research note on Thursday, February 27th. Piper Sandler restated a "neutral" rating and set a $140.00 target price (down previously from $255.00) on shares of Teleflex in a research note on Friday, February 28th. Bank of America downgraded shares of Teleflex from a "neutral" rating to an "underperform" rating and reduced their target price for the stock from $235.00 to $140.00 in a report on Tuesday, March 4th. Wells Fargo & Company cut their price objective on shares of Teleflex from $214.00 to $146.00 and set an "equal weight" rating for the company in a research report on Friday, February 28th. Finally, Raymond James downgraded Teleflex from an "outperform" rating to a "market perform" rating in a research report on Friday, February 28th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus target price of $182.63.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.